Correlation Between Immix Biopharma and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and Tscan Therapeutics, you can compare the effects of market volatilities on Immix Biopharma and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Tscan Therapeutics.
Diversification Opportunities for Immix Biopharma and Tscan Therapeutics
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Immix and Tscan is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between Immix Biopharma and Tscan Therapeutics
Given the investment horizon of 90 days Immix Biopharma is expected to generate 1.06 times less return on investment than Tscan Therapeutics. In addition to that, Immix Biopharma is 1.33 times more volatile than Tscan Therapeutics. It trades about 0.03 of its total potential returns per unit of risk. Tscan Therapeutics is currently generating about 0.05 per unit of volatility. If you would invest 311.00 in Tscan Therapeutics on August 31, 2024 and sell it today you would earn a total of 166.00 from holding Tscan Therapeutics or generate 53.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.73% |
| Values | Daily Returns |
Immix Biopharma vs. Tscan Therapeutics
Performance |
| Timeline |
| Immix Biopharma |
| Tscan Therapeutics |
Immix Biopharma and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immix Biopharma and Tscan Therapeutics
The main advantage of trading using opposite Immix Biopharma and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |